Childhood Cancer

You are here

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile myelomonocytic leukemia (JMML) is a rare type of leukemia that begins from the myeloid cells. It is neither acute (fast-growing) or chronic (slow-growing) and most often occurs in young children (under age 4). 

Make an Impact on Juvenile Myelomonocytic Leukemia (JMML) - Donate now!

Latest Juvenile Myelomonocytic Leukemia (JMML) grants

Alan Cantor, MD, PhD, Principal Investigator
Boston Children's Hospital
Innovation Grants, Awarded 2015
Elliot Stieglitz, MD, Principal Investigator
University of California San Francisco
Young Investigator Grants, Awarded 2015
Mitchell Weiss, M.D., Ph.D., Principal Investigator
Children's Hospital of Philadelphia
Innovation Grants, Awarded 2014

Juvenile Myelomonocytic Leukemia (JMML) Heroes

Latest Juvenile Myelomonocytic Leukemia (JMML) blog posts

by Trish Adkins

For Eden, the trouble began when she was 10 years old. The trouble had a name: pain. It seemed normal at first—maybe a side effect from dancing or growing. But then it never went away and then, suddenly, Eden could not... more
by Trish Adkins

Children with certain types of hard-to-treat childhood cancers just got another huge dose of hope. Last week, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a drug called Vitrakvi (also known... more
by Adam Paris

Eden is a 13 year old who loves to shoot photos and smile for her own snapshots. After being unable to walk or practice her favorite activity, dancing, for nearly a year, she was diagnosed at age 10 with a cancer no doctor... more